Universitätsspital Zürich (USZ)

Hospital


Location: Zürich (Zurich), Switzerland (CH) CH

ISNI: 0000000404789977

ROR: https://ror.org/01462r250

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients (2016) Stoehr C, Stoehr R, Wenners A, Hartmann A, Bertz S, Spath V, Walter B, et al. Journal article DNA methylation in PRDM8 is indicative for dyskeratosis congenita (2016) Weidner CI, Lin Q, Birkhofer C, Gerstenmaier U, Kaifie A, Kirschner M, Bruns H, et al. Journal article Tocilizumab for systemic sclerosis: implications for future trials (2016) Distler O, Distler J Journal article, other Sirt1 regulates canonical TGF-? signalling to control fibroblast activation and tissue fibrosis (2016) Zerr P, Palumbo-Zerr K, Huang J, Tomcik M, Sumova B, Distler O, Schett G, Distler J Journal article Activating transcription factor 3 regulates canonical TGF? signalling in systemic sclerosis (2016) Mallano T, Palumbo-Zerr K, Zerr P, Zeller B, Beyer C, Dees C, Huang J, et al. Journal article Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis (2016) Wohlfahrt T, Usherenko S, Englbrecht M, Dees C, Weber S, Beyer C, Gelse K, et al. Journal article, Original article Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy (2016) Zimmer L, Goldinger SM, Hofmann L, Loquai C, Ugurel S, Thomas I, Schmidgen MI, et al. Journal article The transcription factor GLI2 as a downstream mediator of transforming growth factor-?-induced fibroblast activation in SSc (2016) Liang R, Sumova B, Cordazzo C, Mallano T, Zhang Y, Wohlfahrt T, Dees C, et al. Journal article Patch test results with rubber series in the European Surveillance System on Contact Allergies (ESSCA), 2013/14 (2016) Uter W, Warburton K, Weisshaar E, Simon D, Ballmer-Weber B, Mahler V, Fuchs T, et al. Journal article MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive Glioblastoma: The DIRECTOR Trial (2015) Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, et al. Journal article